Efficacy and Safety of Baroezet Tablet in Korean Patients With Dyslipidemia: A Prospective Observational Study
Clinical trial NCT07515560 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07515560
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-04-30
- Primary completion
- 2027-03-01
- Enrollment
- 12000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.